Non-Compliance at Italian Sterile Manufacturer
Recommendation
Thursday, 12 February 2026 9 .00 - 17.00 h
Best Practice for Manual and Automated Visual Inspection of Parenterals
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In the course of an inspection conducted in October 2018, the Italian health authority discovered several GMP deviations at an Italian manufacturer. The Italian manufacturer produces aseptically prepared LVPs (Large Volume Parenterals) and powders, as well as terminally sterilised LVPs. During the inspection, deficiencies were found in the areas of sterile products (both aseptically prepared and terminally sterilised), secondary packaging and quality control (microbiological, chemical/physical and biological.
The authority has reported 17 major and one "other" deficiencies. The major deficiencies concerned the qualification of critical equipment (autoclaves, depyrogenation tunnels, lyophilisers, CCI testing equipment for ampoules, visual inspection systems). Besides, it has been observed that data integrity was not assured in the quality control equipment and that - all things considered - there was a weak system in place for the investigation of deviations.
As a result of the inspection i.e. of the deficiencies discovered, the manufacturing authorisation of the company has been suspended.
Source: EMA's EudraGMDP database
Related GMP News
03.12.2025What are GMP Audits and what Qualifications do GMP Auditors need to have?
19.11.2025Root Cause Analysis and CAPA - Why FDA Keeps Calling Them Out
22.10.2025EMA Questions & Answers on Mutual Recognition Agreement (MRA) with US updated
22.10.2025FDA continues to take Root Cause Analysis and CAPA very seriously